• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ALX
Click for more information
0.00% $4.79

ATLAS ARTERIA - Corporate Spotlight

Market Cap $6.949B  ! watchlist Created with Sketch. Add to my watchlist
Industrials Railroads

Atlas Arteria Group is an Australia-based global owner, operator, and developer of toll... Atlas Arteria Group is an Australia-based global owner, operator, and developer of toll roads. The Company has a portfolio of five toll roads in France, Germany, and the United States. The Company owns a 31.14% interest in the Autoroutes Paris-Rhin-Rhone (APRR) toll road group in France. In addition to the APRR business is the smaller Autoroute des deux lacs (ADELAC) business, which connects to APRR in southeast France. Together APRR and ADELAC comprise approximately 2,424 kilometers of motorway network located in the East and Southeast of France. In the United States, it owns a 66.67% interest in the Chicago Skyway, a 12.5 kilometers toll road in Chicago and has 100% of the economic interest in the Dulles Greenway, a 22 kilometers toll road in the Commonwealth of Virginia. In Germany, it owns 100% of the Warnow Tunnel in the northeast city of Rostock.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No Corporate Spotlight currently available.

(20min delay)
Last
$4.79 		Change
0.000(0.00%) 		Mkt cap ! $6.949B
Open High Low Value Volume
$4.81 $4.86 $4.77 $614.3K 127.9K

Buyers (Bids)

No. Vol. Price($)
10 3474 $4.78
 

Sellers (Offers)

Price($) Vol. No.
$4.79 11958 17
View Market Depth
Last trade - 10.33am 02/10/2024 (20 minute delay) ?
Last
$4.78 		  Change
0.000 ( 0.22 %)
Open High Low Volume
$4.84 $4.84 $4.77 31588
Last updated 10.52am 02/10/2024 ?
ALX (ASX) Chart

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Firebird achieves preliminary approvals for its Jinshi plant design Firebird Metals Ltd has reached a significant stage in development of its battery-grade manganese sulphate plant in China
PainChek close to finding out if FDA approves its flagship app for use in dementia care PainChek (ASX:PCK) has updated the market on the progress of its De Novo submission to the US FDA for its flagship app in aged care settings.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.